Avonex
Links shared publicly online about this topic
Avonex IM Uses and How to Use
healthcentral.com — “Avonex side effects, dosage, and drug interactions. All accurate, up-to-date information is written for the consumer by healthcare professionals.” View full resource at healthcentral.com
Most Recently Shared on September 2, 2011 at 8:29 pm By:
HealthCentral Tips Health Site
@PetraW1976 Sure do. We've got the basic usage & used for information for it here: http://t.co/FbgaP5T #MultipleSclerosis
Brass and Ivory: Too tired to blog. Read about Biogen and Avonex instead.
brassandivory.blogspot.com — “Support and advice for living and coping with multiple sclerosis and rheumatoid arthritis. Read about one woman\” View full resource at brassandivory.blogspot.com
Most Recently Shared on September 16, 2009 at 7:21 pm By:
Too tired to blog. Read about Biogen and Avonex instead.: I am so utterly exhausted and fatigued that I can hard.. http://bit.ly/1Z254u
Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced today that the European Commission (EC) has granted approval to AVONEX PEN for patients with relapsing multiple sclerosis (MS) and patients who have had a sing” View full resource at medicalnewstoday.com
Most Recently Shared on June 7, 2011 at 12:06 pm By:
Biogen Idec Receives Approval In The European Union For AVONEX(R) PEN™ http://mnt.to/3WRt #multiplesclerosis
Biogen Idec Receives Positive Opinion From The CHMP And Authorisation From Health Canada On AVONEX PEN
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVO” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2011 at 12:05 pm By:
Biogen Idec Receives Positive Opinion From The CHMP And Authorisation From Health Canada On AVONEX PEN http://mnt.to/3TPF #multiplesclerosis
Biogen Idec Reports Positive Data From AVONEX Dose Titration Study At 2011 Annual Meeting Of The Consortium Of Multiple Sclerosis Centers
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX®(interferon beta-1a) dose titration, or” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 3:05 pm By:
Biogen Idec Reports Positive Data From AVONEX Dose Titration Study At 2011 Annual Meeting Of The Consortium Of Multipl... http://mnt.to/3WNZ
Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interferon And Glatiramer Acetate For The Treatment Of Multiple Sclerosis
medicalnewstoday.com — “Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantl” View full resource at medicalnewstoday.com
Most Recently Shared on September 13, 2009 at 11:50 am By:
MedNewsToday: Fewer Injection Site Reactions In Patients Using AVONEX Versus Sub-cutaneous Interfer.. http://bit.ly/cBg1N
First 10-YTear Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) has announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surve” View full resource at medicalnewstoday.com
Most Recently Shared on May 2, 2009 at 11:07 am By:
MedNewsToday: First 10-YTear Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits.. http://tinyurl.com/cfwmlh
First Ten-Year Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS ( C ontrolled H igh-Risk A VONEX ® (interferon beta-1a) M ultiple Sclerosis (MS) P revention Study I n O ngoing N eurologi” View full resource at medicalnewstoday.com
Most Recently Shared on May 4, 2009 at 3:03 pm By:
MedNewsToday: First Ten-Year Follow-Up Shows That Treatment With AVONEX Leads To Long-Term Benefits.. http://tinyurl.com/cpbwxv
Biogen Idec Reports Positive Data from AVONEX Dose Titration Study at 2011 Annual Meeting of the Consortium of Multiple Sclerosis Centers - Drugs.com MedNews
drugs.com — “-Data Show that Titrating AVONEX at Initiation of Treatment Reduced Severity of Flu-like Symptoms- Jun 6, 2011 - Biogen Idec (NASDAQ BIIB) today announced the f” View full resource at drugs.com
Most Recently Shared on June 6, 2011 at 2:07 pm By:
Drugs and Devices OW OW Health
Biogen Idec Reports Positive Data from AVONEX Dose Titration Study at 2011 Annual Meeting of the Consortiu... http://bit.ly/mJMKtF #drug
First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveilla” View full resource at medicalnewstoday.com
Most Recently Shared on July 4, 2009 at 11:05 am By:
MedNewsToday: First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefit.. http://tinyurl.com/nguutu
First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) today announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Sur” View full resource at medicalnewstoday.com
Most Recently Shared on September 8, 2009 at 11:52 am By:
MedNewsToday: First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefit.. http://bit.ly/1qsCyy
Avonex and Prozac (and more) drug interaction: Anxiety (Stress and anxiety). An extension of study (ID: 275362) from 3 people - eHealthMe.com
ehealthme.com — “Real world drug outcomes: Anxiety in Avonex, Prozac, Provigil. Who have it and how? An extension of study (ID: 275362)” View full resource at ehealthme.com
Most Recently Shared on May 7, 2011 at 3:30 pm By:
Peter H Brown Doctor and Psychologist
Avonex and Prozacand more drug interaction AnxietyStress and ... http://bit.ly/mFwcjM #anxiety #stress
Medications for MS: What--™s the difference between interferon beta-1a and interferon beta-1b? - Multiple Sclerosis
healthcentral.com — “Four of the seven currently available disease-modifying MS drugs are often referred to as “the interferons” - Avonex, Rebif, Betaseron, and Extavia....” View full resource at healthcentral.com
Most Recently Shared on December 1, 2010 at 4:36 pm By:
Medications for MS: What's the difference between interferon beta-1a and interferon beta-1b? http://ow.ly/1afB1E
UPDATE 1-Biogen takes control of JVs in Italy, Switzerland | Reuters
reuters.com — “* Biogen acquires full control of ventures with Dompe * Joint ventures are in Italy and Switzerland BOSTON, Sept. 6 (Reuters) - Biogen Idec Inc saidon Tuesday it has taken control of” View full resource at reuters.com
Most Recently Shared on September 6, 2011 at 1:33 pm By:
Biogen takes over marketing JV's that had been selling its MS meds Avonex, Tysabri in 29 countries http://t.co/IegyTWl $BIIB #pharma
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis - Multiple Sclerosis
healthcentral.com — “Even before I was diagnosed with MS in 2005, I researched the different treatment options. I learned about the ABC’s (Avonex, Betaseron, Copaxone),...” View full resource at healthcentral.com
Most Recently Shared on October 5, 2010 at 8:30 pm By:
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis http://ow.ly/19iRvv
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
HealthCentral Tips
News and Views on everything health! ADD/ADHD, Mental Health, Cancer, Anxiety, Depression, Kid's Health, Sexual Health, Fitness, Chronic Pain, MS, RA etc.
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
MNT Multiple Scl
The latest multiple sclerosis news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
